Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)

International Immunopharmacology

Volumn 11, Issue 12, 2011, Pages 2188-2193

  Zheng, Yi ^a,b   Guo, Changyuan ^a,b   Zhang, Yan ^a,b   Qi, Hui ^a,b   Sun, Qianying ^a,b   Xu, Enquan ^a,b   Zhang, Yingmei ^a,b   Ma, Dalong ^a,b   Wang, Ying ^a,b  

^a PEKING UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Allergic rhinitis; Animal models; CKLF1; Peptide

Indexed keywords

BUDESONIDE; C 19; C PEPTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; OVALBUMIN; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; EOSINOPHIL; EOSINOPHILIA; FEMALE; IMMUNOPATHOGENESIS; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SENSITIZATION; SNEEZING; TH2 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKIN-4; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; PEPTIDES; REPRESSOR PROTEINS; RHINITIS, ALLERGIC, PERENNIAL; SNEEZING;

EID: 81855221943     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.09.017     Document Type: Article

References (21)

1. D.P. Skoner Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis J Allergy Clin Immunol 108 2001 S2 S8
2. E. Compalati, E. Ridolo, G. Passalacqua, F. Braido, E. Villa, and G.W. Canonica The link between allergic rhinitis and asthma: the united airways disease Expert Rev Clin Immunol 6 2010 413 423
3. Y. Hiromura, T. Kishida, H. Nakano, T. Hama, J. Imanishi, and Y. Hisa IL-21 administration into the nostril alleviates murine allergic rhinitis J Immunol 179 2007 7157 7165
4. G. Banfield, H. Watanabe, and G. Scadding CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses Allergy 65 2010 1126 1133
5. L.I. Willems, and A.P. Ijzerman Small molecule antagonists for chemokine CCR3 receptors Med Res Rev 30 2009 778 817
6. K.D. Stone, C. Prussin, and D.D. Metcalfe IgE, mast cells, basophils, and eosinophils J Allergy Clin Immunol 125 2010 S73 S80
7. C.E. Owen Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic Pharmacol Ther 113 2007 121 133 (Pubitemid 46001821)
8. N. Fukui, K. Honda, E. Ito, and K. Ishikawa Peroxisome proliferator-activated receptor gamma negatively regulates allergic rhinitis in mice Allergol Int 58 2009 247 253
9. Y. Wang, Y. Zhang, W. Han, D. Li, L. Tian, and C. Yin Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4 Int J Biochem Cell Biol 40 2008 909 919
10. W. Han, Y. Lou, and J. Tang Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity Biochem J 357 2001 127 135 (Pubitemid 32642910)
11. L. Tian, W. Li, and J. Wang The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma Allergy 66 2011 287 297
12. K.S. Lee, H.K. Lee, J.S. Hayflick, Y.C. Lee, and K.D. Puri Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model FASEB J 20 2006 455 465 (Pubitemid 44933322)
13. L. Rosenwasser New insights into the pathophysiology of allergic rhinitis Allergy Asthma Proc 28 2007 10 15
14. S.A. Brunton, and L.M. Fromer Treatment options for the management of perennial allergic rhinitis, with a focus on intranasal corticosteroids South Med J 100 2007 701 708 (Pubitemid 47056520)
15. A.J. Trangsrud, A.L. Whitaker, and R.E. Small Intranasal corticosteroids for allergic rhinitis Pharmacotherapy 22 2002 1458 1467 (Pubitemid 35266382)
16. S. Holgate, T. Casale, S. Wenzel, J. Bousquet, Y. Deniz, and C. Reisner The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation J Allergy Clin Immunol 115 2005 459 465 (Pubitemid 40341694)
17. K. Verbruggen, P. Van Cauwenberge, and C. Bachert Anti-IgE for the treatment of allergic rhinitis-and eventually nasal polyps? Int Arch Allergy Immunol 148 2009 87 98
18. K. Oboki, T. Ohno, H. Saito, and S. Nakae Th17 and allergy Allergol Int 57 2008 121 134 (Pubitemid 351897666)
19. O. Palomares, G. Yaman, A.K. Azkur, T. Akkoc, M. Akdis, and C.A. Akdis Role of Treg in immune regulation of allergic diseases Eur J Immunol 40 2010 1232 1240
20. K. Ohga, S. Kuromitsu, R. Takezawa, M. Numazaki, J. Ishikawa, and S. Nagashima YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models Eur J Pharmacol 590 2008 409 416
21. B.F. Marple Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids Allergy Asthma Proc 29 2008 232 240